{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/goss-4-day-deadline-alert-gossamer-bio-investors-with-losses-may-seek-to-lead-the-class-action-after-executives-allegedly-concealed-placebo-risk-hbss-302784135.html", "message": "News view counter 763654 successfully enlarged"}